-
MK-5108 and the Aurora A Opportunity in Retinoblastoma
2026-09-17
Aurora A is emerging as a mechanistically credible vulnerability in aggressive retinoblastoma. This article connects patient-tissue evidence with the selective pharmacology of MK-5108 (VX-689), outlining how translational researchers can move from AURKA expression to causal validation, assay design, biomarker strategy, and more disciplined interpretation of preclinical efficacy.
-
R2 Retrotransposon Insertions and DNA Repair Pathways
2026-09-17
McIntyre, Horton, and Collins show that stable insertions initiated by R2 target-primed reverse transcription can be completed through alternative human DNA repair pathways. Their PRINT-based study links intact or truncated transgene products to distinct junction-forming mechanisms, clarifying how non-LTR retrotransposon cDNA becomes integrated into the genome.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-09-16
FITC-Concanavalin A (ConA) Conjugate, SKU K4413, provides direct fluorescent detection of accessible α-D-glucose and α-D-mannose moieties on cell-surface glycoproteins and glycolipids. It is suited to immunofluorescence, fluorescence microscopy, tissue staining, and flow cytometry carbohydrate analysis, but it should not be used as a universal cell stain or for identifying a specific non-carbohydrate target.
-
Berberrubine chloride: Applied Research Workflows
2026-09-16
Berberrubine chloride is a DMSO-soluble research compound for connecting cancer-cell phenotypes with IMPDH2, TrxR, inflammatory, and urate-transporter biology. This practical guide shows how to build dose-response experiments, investigate cisplatin sensitization, and add CYP2D6 mechanism-based inhibition assays without confusing exploratory findings with clinical evidence.
-
Sildenafil Citrate: Proteoform-Aware Assay Design
2026-09-15
Sildenafil Citrate is more than a potent PDE5 tool: its signaling effects must be interpreted in relation to native membranes, proteoforms, and downstream vascular phenotypes. This guide develops a proteoform-aware assay strategy grounded in native mass spectrometry and practical cGMP research.
-
CGP 55845 hydrochloride in Cell Assays
2026-09-15
CGP 55845 hydrochloride, SKU B5086, offers a defined way to separate GABAB receptor signaling from nonspecific changes in viability, proliferation, or cytotoxicity readouts. This scenario-based guide connects its documented pharmacology with practical controls for in vitro neurotransmission assays and exploratory hypoglycemia mechanism studies.
-
Bafilomycin A1 in Lysosomal and Cancer Assays
2026-09-14
Bafilomycin A1 provides reversible, nanomolar V-ATPase inhibition for connecting organellar acidification with lysosomal, osteoclast, and cancer-cell phenotypes. This workflow-oriented guide shows how to pair pH measurements with phase-resolved cell-death assays while avoiding common interpretation and dosing errors.
-
2-Hydroxypropyl-β-cyclodextrin Workflow Guide
2026-09-14
2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide used to screen and improve the apparent aqueous solubility of poorly soluble hydrophobic compounds, particularly molecules containing aromatic or phenyl groups. This guide supports pharmaceutical and biochemical research workflows, but it does not establish compound-specific clinical efficacy, universal bioavailability improvement, or suitability for unrelated applications.
-
GPR35–KLF5 Signaling in DSS Colitis Repair
2026-09-13
A recent Cell Death and Disease study identifies GPR35 as a metabolic sensor that links the tryptophan–kynurenine–kynurenic acid axis to KLF5-dependent intestinal epithelial repair. Its findings connect metabolite sensing with PI3K–AKT–mTOR signaling, epithelial proliferation, and migration, refining how DSS colitis models can be interpreted in ulcerative colitis research.
-
ATRX-Deficient Glioma and RTK Inhibitor Sensitivity
2026-09-12
The reference study shows that ATRX-deficient high-grade glioma cells are more vulnerable than ATRX-proficient comparators to several receptor tyrosine kinase and PDGFR inhibitors. It further reports pronounced toxicity when selected RTK inhibitors are combined with temozolomide, supporting ATRX status as a potentially important variable in glioma drug studies and clinical-trial interpretation.
-
X-press Tag Peptide for RHEB Assays
2026-09-11
X-press Tag Peptide combines a polyhistidine handle, Xpress epitope, and enterokinase site in one N-terminal leader peptide for capture, detection, and controlled release. Its modular design is especially useful for recombinant RHEB workflows that test neddylation-linked regulation of mTORC1.
-
CX-5461 Workflow for Pol I Inhibition in Cancer
2026-09-11
CX-5461 is an RNA polymerase I inhibitor that turns ribosome-biogenesis research into a measurable workflow spanning rRNA transcription, DNA damage, mitotic catastrophe, senescence, and autophagy. This guide translates its reported activity in solid tumors and cervical cancer into practical assay design, combination testing, and troubleshooting decisions.
-
CGP 55845 Hydrochloride in Synaptic Assays
2026-09-10
Use CGP 55845 hydrochloride as a selective pharmacological gate to separate GABAB-dependent signaling from astrocytic GAT-3 effects in dentate gyrus experiments. This practical guide combines receptor antagonism, patch-clamp readouts, neurotransmitter release modulation, and troubleshooting for reproducible in vitro workflows.
-
Salinomycin: Mechanism and HCC Research Use
2026-09-10
Salinomycin is a polyether ionophore antibiotic studied in hepatocellular carcinoma research. Supplier-described findings connect cation transport, calcium elevation, Wnt/β-catenin suppression, proliferation arrest, and apoptosis, but the compound remains an experimental research reagent rather than an approved treatment.
-
CGP 55845 hydrochloride in GABA Circuit Analysis
2026-09-09
CGP 55845 hydrochloride is a high-affinity GABAB receptor antagonist for dissecting presynaptic control of neurotransmitter release. This article presents a causal assay framework that separates neuronal receptor signaling from astrocytic GAT-3 mechanisms in synaptic transmission research.